Cargando…

Can the Edinburgh Postnatal Depression Scale-3A be used to screen for anxiety?

BACKGROUND: Anxiety in the ante- and postnatal period is prevalent, often co-occurs with depression, and can have adverse consequences for the infant. Therefore, perinatal mental health screening programs should not only focus on depression but also on detecting anxiety. However, in many already imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith-Nielsen, Johanne, Egmose, Ida, Wendelboe, Katrine Isabella, Steinmejer, Pernille, Lange, Theis, Vaever, Mette Skovgaard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349495/
https://www.ncbi.nlm.nih.gov/pubmed/34364392
http://dx.doi.org/10.1186/s40359-021-00623-5
_version_ 1783735575708172288
author Smith-Nielsen, Johanne
Egmose, Ida
Wendelboe, Katrine Isabella
Steinmejer, Pernille
Lange, Theis
Vaever, Mette Skovgaard
author_facet Smith-Nielsen, Johanne
Egmose, Ida
Wendelboe, Katrine Isabella
Steinmejer, Pernille
Lange, Theis
Vaever, Mette Skovgaard
author_sort Smith-Nielsen, Johanne
collection PubMed
description BACKGROUND: Anxiety in the ante- and postnatal period is prevalent, often co-occurs with depression, and can have adverse consequences for the infant. Therefore, perinatal mental health screening programs should not only focus on depression but also on detecting anxiety. However, in many already implemented perinatal screening programs, adding extra screening instruments is not feasible. We examine the utility of a subscale of the Edinburgh Postnatal Depression Scale (EPDS) consisting of items 3, 4, and 5 (EPDS-3A) for detecting anxiety in new mothers. METHODS: We used confirmatory factor analysis (CFA) to confirm the presence of the EPDS-3A found in a previous study (n = 320) where exploratory factor analysis (EFA) was used. For the CFA we used a sample of new mothers (n = 442) with children aged 2–11 months recruited from the same population from which mothers for the previous study was recruited. Three models were tested and compared. Receiver operating characteristics of the EPDS-3A were investigated in relation to anxiety caseness status on the combined sample (N = 762). Sample weighing was used to match the dataset to the target population. Cross tabulation was used to investigate the proportion of anxiety cases identified by the EPDS-3A above those identified with the total EPDS. RESULTS: The presence of the EPDS-3A was confirmed. An EFA-driven, two-dimensional 7-item model showed the best data fit with one factor representing the anxiety subscale consisting of items 3, 4, and 5. An EPDS-3A score of ≥ 5 was the most optimal for identifying cases of anxiety (sensitivity: 70.9; specificity: 92.2; AUC: 0.926). Further, we found that the EPDS-3A identifies an additional 2.5% of anxiety cases that would not have been identified with the total EPDS. CONCLUSIONS: The EPDS-3A can be used as a time-efficient screening for possible anxiety in ante- and postnatal mothers. However, adding the EPDS-3A to routine screening with the total EPDS does not lead to a substantial increase in the number of women identified. In line with previous studies, this study confirms that the EPDS identifies anxiety in addition to depression. Therefore, assessment and treatment adjusted to the specific emotional difficulties is imperative. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40359-021-00623-5.
format Online
Article
Text
id pubmed-8349495
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-83494952021-08-09 Can the Edinburgh Postnatal Depression Scale-3A be used to screen for anxiety? Smith-Nielsen, Johanne Egmose, Ida Wendelboe, Katrine Isabella Steinmejer, Pernille Lange, Theis Vaever, Mette Skovgaard BMC Psychol Research BACKGROUND: Anxiety in the ante- and postnatal period is prevalent, often co-occurs with depression, and can have adverse consequences for the infant. Therefore, perinatal mental health screening programs should not only focus on depression but also on detecting anxiety. However, in many already implemented perinatal screening programs, adding extra screening instruments is not feasible. We examine the utility of a subscale of the Edinburgh Postnatal Depression Scale (EPDS) consisting of items 3, 4, and 5 (EPDS-3A) for detecting anxiety in new mothers. METHODS: We used confirmatory factor analysis (CFA) to confirm the presence of the EPDS-3A found in a previous study (n = 320) where exploratory factor analysis (EFA) was used. For the CFA we used a sample of new mothers (n = 442) with children aged 2–11 months recruited from the same population from which mothers for the previous study was recruited. Three models were tested and compared. Receiver operating characteristics of the EPDS-3A were investigated in relation to anxiety caseness status on the combined sample (N = 762). Sample weighing was used to match the dataset to the target population. Cross tabulation was used to investigate the proportion of anxiety cases identified by the EPDS-3A above those identified with the total EPDS. RESULTS: The presence of the EPDS-3A was confirmed. An EFA-driven, two-dimensional 7-item model showed the best data fit with one factor representing the anxiety subscale consisting of items 3, 4, and 5. An EPDS-3A score of ≥ 5 was the most optimal for identifying cases of anxiety (sensitivity: 70.9; specificity: 92.2; AUC: 0.926). Further, we found that the EPDS-3A identifies an additional 2.5% of anxiety cases that would not have been identified with the total EPDS. CONCLUSIONS: The EPDS-3A can be used as a time-efficient screening for possible anxiety in ante- and postnatal mothers. However, adding the EPDS-3A to routine screening with the total EPDS does not lead to a substantial increase in the number of women identified. In line with previous studies, this study confirms that the EPDS identifies anxiety in addition to depression. Therefore, assessment and treatment adjusted to the specific emotional difficulties is imperative. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40359-021-00623-5. BioMed Central 2021-08-07 /pmc/articles/PMC8349495/ /pubmed/34364392 http://dx.doi.org/10.1186/s40359-021-00623-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Smith-Nielsen, Johanne
Egmose, Ida
Wendelboe, Katrine Isabella
Steinmejer, Pernille
Lange, Theis
Vaever, Mette Skovgaard
Can the Edinburgh Postnatal Depression Scale-3A be used to screen for anxiety?
title Can the Edinburgh Postnatal Depression Scale-3A be used to screen for anxiety?
title_full Can the Edinburgh Postnatal Depression Scale-3A be used to screen for anxiety?
title_fullStr Can the Edinburgh Postnatal Depression Scale-3A be used to screen for anxiety?
title_full_unstemmed Can the Edinburgh Postnatal Depression Scale-3A be used to screen for anxiety?
title_short Can the Edinburgh Postnatal Depression Scale-3A be used to screen for anxiety?
title_sort can the edinburgh postnatal depression scale-3a be used to screen for anxiety?
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349495/
https://www.ncbi.nlm.nih.gov/pubmed/34364392
http://dx.doi.org/10.1186/s40359-021-00623-5
work_keys_str_mv AT smithnielsenjohanne cantheedinburghpostnataldepressionscale3abeusedtoscreenforanxiety
AT egmoseida cantheedinburghpostnataldepressionscale3abeusedtoscreenforanxiety
AT wendelboekatrineisabella cantheedinburghpostnataldepressionscale3abeusedtoscreenforanxiety
AT steinmejerpernille cantheedinburghpostnataldepressionscale3abeusedtoscreenforanxiety
AT langetheis cantheedinburghpostnataldepressionscale3abeusedtoscreenforanxiety
AT vaevermetteskovgaard cantheedinburghpostnataldepressionscale3abeusedtoscreenforanxiety